Sep 2026
Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions.
Plasma p-tau217 is established as a first-choice biomarker for the early detection of AD pathology in specialized clinical settings, displaying excellent diagnostic accuracy and minimal site-related variability.
A. Sánchez-Soblechero, A. Villarejo, M. Carreras et al.
· Journal of Alzheimer's Disea... · 0 citations